Cargando…

Role of lower dose hepatitis B immune globulin prophylaxis in liver transplantation: A single center perspective

BACKGROUND AND AIM: Prevention of hepatitis B virus (HBV) reinfection is important for long-term outcomes following liver transplantation (LT). Hepatitis B immunoglobulin (HBIG) is used among recipients who have (i) native HBV disease, (ii) hepatitis B core antibody positivity (HBcAb positivity), or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, Diep, Lin, Jessica, Toman, Lindsey, Gurakar, Merve, Pustavoitau, Aliaksei, Kohli, Ruhail, Wesson, Russel, Ottmann, Shane E., Dao, Doan, Gurakar, Ahmet, Kim, Ahyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951898/ https://www.ncbi.nlm.nih.gov/pubmed/36843892 http://dx.doi.org/10.14744/hf.2022.2022.0030

Ejemplares similares

Hepatitis B Virus/Hepatitis D Virus–Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid–Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin
por: Hammami, Muhammad Baraa, et al.
Publicado: (2021)

High Coronary Artery Calcium Score Is Associated With Increased Major Adverse Cardiac Events After Liver Transplantation
por: Su, Amanda, et al.
Publicado: (2023)

Exertional Heat Stroke-Induced Acute Liver Failure and Liver Transplantation
por: Lin, Jessica S., et al.
Publicado: (2022)

Liver transplantation in developing countries
por: Ozturk, Nazli Begum, et al.
Publicado: (2022)

Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review
por: Muhammad, Haris, et al.
Publicado: (2021)

Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series
por: Simsek, Cem, et al.
Publicado: (2020)

Donor BMI and Post–living Donor Liver Transplantation Outcomes: A Preliminary Report
por: Lin, Jessica S., et al.
Publicado: (2023)

Update on Liver Transplantation: What is New Recently?
por: Tasdogan, Burcak E, et al.
Publicado: (2019)

Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature
por: Cosarderelioglu, Caglar, et al.
Publicado: (2016)

Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review
por: Mitchell, Oscar, et al.
Publicado: (2015)

Current Concepts in Hepatocellular Carcinoma and Liver Transplantation: A Review and 2014 Update
por: Ofosu, Andrew, et al.
Publicado: (2015)

Liver Transplantation Update: 2014
por: Dogan, Serkan, et al.
Publicado: (2015)

Tackling HCV-3 in Asia: Breakthroughs for Efficient and Cost-effective Treatment Strategies
por: Saeed, Naba, et al.
Publicado: (2016)

From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis
por: Aljabban, Jihad, et al.
Publicado: (2020)

Update on liver transplantation-newer aspects
por: METİN, Olga, et al.
Publicado: (2020)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis
por: Koksal, Deniz, et al.
Publicado: (2016)

Transplant of SARS-CoV-2–infected Living Donor Liver: Case Report
por: Nguyen, Michelle C., et al.
Publicado: (2021)

Greater Biosynthetic Liver Dysfunction in Primary Sclerosing Cholangitis Suggests Co-existent or Impending Cholangiocarcinoma
por: Trilianos, Panagiotis, et al.
Publicado: (2016)

Current Management of Alcoholic Hepatitis and Future Therapies
por: Saberi, Behnam, et al.
Publicado: (2016)

Update on Immunosuppression in Liver Transplantation
por: Tasdogan, Burcak E, et al.
Publicado: (2019)

Practice patterns and considerations in liver transplantation from living donors with high BMI: A review
por: Samaha, Carl, et al.
Publicado: (2023)

Case Report: Vancomycin-Induced Thrombocytopenia in a Burn Patient
por: Pauldine, Ronald, et al.
Publicado: (2008)

Sudden Cardiac Arrest Secondary to Early Repolarization Syndrome
por: Chilazi, Michael, et al.
Publicado: (2021)

Hepatitis D virus and liver transplantation: Indications and outcomes
por: Muhammad, Haris, et al.
Publicado: (2021)

Liver Transplantation for Budd-Chiari Syndrome in the MELD Era
por: Alqahtani, Saleh A., et al.
Publicado: (2022)

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
por: Dindoost, Payam, et al.
Publicado: (2012)

Intracorporeal Heat Distribution from Fully Implantable Energy Sources for Mechanical Circulatory Support: A Computational Proof-of-Concept Study
por: Biasetti, Jacopo, et al.
Publicado: (2017)

Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis
por: Nelson, Noele P.
Publicado: (2017)

Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change
por: Saberi, Behnam, et al.
Publicado: (2023)

Comparison of Intravitreal Dexamethasone Implant and Intravitreal Ranibizumab Efficacy in Younger Patients with Branch Retinal Vein Occlusion
por: Ozcift, Seda Gurakar, et al.
Publicado: (2023)

An Update on Usage of High-Risk Donors in Liver Transplantation
por: Muhammad, Haris, et al.
Publicado: (2021)

Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation
por: Da, Ben L., et al.
Publicado: (2020)

Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy
por: Ko, Eun Jeong, et al.
Publicado: (2019)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
por: Immohr, Moritz B., et al.
Publicado: (2021)

Does rabbit anti-thymocyte globulin dose and antiviral prophylaxis alter the risk of the development of PTLD in renal transplant population?
por: Mohamed, Mahmoud, et al.
Publicado: (2020)

Endoscopic submucosal dissection for Barrett’s-associated adenocarcinoma in a patient with decompensated cirrhosis and esophageal varices
por: Mohapatra, Sonmoon, et al.
Publicado: (2020)

The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease
por: Ali, Robert, et al.
Publicado: (2017)

Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT
por: van der Velden, Walter J. F. M., et al.
Publicado: (2021)

Adherence to guideline recommendations for human rabies immune globulin patient selection, dosing, timing, and anatomical site of administration in rabies postexposure prophylaxis
por: Hwang, Grace S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fg8o21m2if4n5qsvr169i11vjm